Patients qualified for SPS3 if they were aged ≥30 and had experienced a recent symptomatic lacunar stroke, defined as a typical clinical syndrome along with a compatible magnetic resonance ...

Although short-term dual antiplatelet therapy may eventually prove to benefit specific populations with very high stroke risk, the SPS3 trial definitively establishes that lacunar stroke alone is ...

Lacunar stroke is a marker of cerebral small vessel disease and accounts for up to 25% of ischaemic stroke. In this narrative review, we provide an overview of potential lacunar stroke mechanisms and ...

Stroke’s facial symptoms include drooping, muscle weakness, and paralysis. A person’s eyelids, cheeks, or mouth may droop on one or both sides, and they may have an involuntary smile or be ...

Stroke Unit, Clinique Neurologique, Department of Clinical and Biological Neurosciences, Grenoble, France. This study concerns the long-term prognosis of lacunar infarcts. We report the analysis of ...

Intravenous tenecteplase bridging boosted the benefit of endovascular thrombectomy for acute ischemic stroke patients who presented within 4.5 hours after onset, the BRIDGE-TNK trial from China ...

None of the 291 patients had complications with CTA. 118 In multivariable analysis, younger age, location of ICH, absence of signs of small vessel disease (defined as presence of white matter lesions ...

Background Predicting the final infarct after an extended time window mechanical thrombectomy (MT) is beneficial for treatment planning in acute ischemic stroke (AIS). By introducing guidance from ...

Strokes are on the rise among younger people, with a recent report from the Centers for Disease Control and Prevention revealing that between 2020 and 2022, there was a 14.6% increase of strokes ...